PMID: 7544252Aug 1, 1995Paper

CD5 expression on B cells may be an activation marker for secretion of anti-myelin antibodies in patients with polyneuropathy associated with monoclonal gammopathy

Clinical and Experimental Immunology
C EkerfeltM Vrethem

Abstract

B cells expressing the CD5 marker belong to a subpopulation with potential autoreactive properties. Increased proportions of CD5+ B cells have been reported in autoimmune diseases. In patients with monoclonal gammopathy and demyelinating polyneuropathy, the M-component often consists of autoantibodies reacting with myelin components. We therefore investigated if CD5+ B cells were involved in the production of anti-myelin antibodies. There was no difference of mean value of CD5+ B cells between patients and controls. However, the proportion of CD5+ B cells was significantly correlated with the amount of anti-myelin antibodies. In seven patients, CD5+ B cells were enriched using an immunomagnetic technique. The number of CD5+ and CD5- B cells secreting anti-myelin antibodies was determined by ELISPOT. In two patients with high levels of antibodies, antibody-secreting cells were mainly, but not exclusively, CD5+ B cells. In five patients with low levels of antibodies, most cells secreting anti-myelin antibodies were CD5-. We conclude that CD5 expressed on B cells may be an activation marker, reflecting B cells producing high amounts of anti-myelin antibodies in patients with polyneuropathy associated with monoclonal gammopathy.

References

Jan 1, 1992·International Journal of Clinical & Laboratory Research·E S RavechéB Peng
Nov 1, 1991·Immunology Today·A B Kantor
Nov 1, 1991·Immunology Today·A Kantor
Jul 1, 1989·European Journal of Immunology·C Werner-FavreR H Zubler
Jun 1, 1989·Journal of Autoimmunity·C Plater-ZyberkR N Maini
May 1, 1988·Arthritis and Rheumatism·M DauphinéeN Talal
Jan 1, 1970·Acta Neurologica Scandinavica. Supplementum·J Prineas
Jan 1, 1968·Scandinavian Journal of Clinical and Laboratory Investigation·C E Mogensen
Nov 1, 1982·Journal of Neurochemistry·P E BraunN Latov
Sep 11, 1980·The New England Journal of Medicine·N LatovE F Osserman
Dec 16, 1983·Journal of Immunological Methods·C C CzerkinskyA Tarkowski
Jun 1, 1994·Journal of Neuroimmunology·M OginoN Latov
May 1, 1993·Clinical and Experimental Immunology·C JaminP Youinou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.